Advaxis Provides Phase 1 Data of Higher Dose Axalimogene Filolisbac
Mar 27, 2017 12:03 pm UTC| Business
PRINCETON, N.J., March 27, 2017 -- Advaxis, Inc. (NASDAQ:ADXS), a biotechnology company developing cancer immunotherapies, today published online a poster previously presented at the National Cancer Research Institute...
Advaxis Provides Phase 1 Data of Higher Dose Axalimogene Filolisbac
Mar 27, 2017 12:03 pm UTC| Business
PRINCETON, N.J., March 27, 2017 -- Advaxis, Inc. (NASDAQ:ADXS), a biotechnology company developing cancer immunotherapies, today published online a poster previously presented at the National Cancer Research Institute...
Ekso Bionics to Present at the Groundbreak 2017 Construction Conference
Mar 27, 2017 12:03 pm UTC| Business
RICHMOND, Calif., March 27, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced that Russ Angold, the company’s co-founder and chief technology officer, will be a presenter...
Professional Diversity Network Releases Letter from CEO to Shareholders
Mar 27, 2017 12:03 pm UTC| Business
CHICAGO, March 27, 2017 -- Professional Diversity Network, Inc. (“PDN” or “the Company”) (NASDAQ:IPDN) today released a letter from its CEO to its shareholders. Dear PDN Shareholders, Last year I led a group of...
Professional Diversity Network Releases Letter from CEO to Shareholders
Mar 27, 2017 12:03 pm UTC| Business
CHICAGO, March 27, 2017 -- Professional Diversity Network, Inc. (“PDN” or “the Company”) (NASDAQ:IPDN) today released a letter from its CEO to its shareholders. Dear PDN Shareholders, Last year I led a group of...
Mar 27, 2017 12:02 pm UTC| Business
PARIS, March 27, 2017 -- BIOPHYTIS (Alternext Paris:ALBPS), a biotechnology company specialized in the development of drug candidates to treat ageing diseases, announced that the first clinical centers leading the...
Mar 27, 2017 12:02 pm UTC| Business
NEW YORK, March 27, 2017 -- Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces it has reached a Special Protocol...